Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Protein Induced by Vitamin K Absence or Antagonist-II”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableUnknownNCT04414956
What this trial is testing

Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma

Who this might be right for
Liver CirrhosisHepatocellular CarcinomaSurveillance
Korea University 1,418
Not applicableStudy completedNCT03047603
What this trial is testing

Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 4,005
Not applicableNot Yet RecruitingNCT06331260
What this trial is testing

Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma

Who this might be right for
Liver TransplantationHepatocellular CarcinomaAlpha-Fetoprotein+1 more
Zhejiang University 600
Not applicableLooking for participantsNCT06960954
What this trial is testing

PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma

Who this might be right for
Hepato Cellular Carcinoma (HCC)Portal Vein Tumour Thrombosis
Tanta University 116
Not applicableUnknownNCT01846949
What this trial is testing

Surveillance Study for HCC by Combining Biomarkers With Imaging (ALDUS)

Who this might be right for
Liver Cirrhosis
ALDUS Study Group 1,000
Not applicableNot Yet RecruitingNCT07620236
What this trial is testing

The OK Daily Study

Who this might be right for
Infant Vitamin K StatusVitamin K Deficiency Bleeding
Norfolk and Norwich University Hospitals NHS Foundation Trust 134
Not applicableStudy completedNCT04770740
What this trial is testing

Randomized Controlled Clinical Trial to Investigate Effects of Vitamin K2 in COVID-19

Who this might be right for
Covid19
Canisius-Wilhelmina Hospital 40
Not applicableUnknownNCT01277653
What this trial is testing

Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Yonsei University 1,000
Not applicableStudy completedNCT03460080
What this trial is testing

Diagnostic Value of AFP-L3 and PIVKA-II in HCC

Who this might be right for
Hepatocellular Carcinoma
Hanoi Medical University 200
Not applicableStudy completedNCT05907772
What this trial is testing

Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma

Who this might be right for
Cancer of Liver
Zhejiang University 522
Not applicableStudy completedNCT03645655
What this trial is testing

PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants

Who this might be right for
HepatoblastomaHepatic Hemangioendothelioma
Shanghai Children's Medical Center 257
Not applicableEnrolling By InvitationNCT07298577
What this trial is testing

Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer

Who this might be right for
Liver CirrhosisHepatitis B, ChronicHepatitis C, Chronic+1 more
Siriraj Hospital 2,100